These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 17160212
1. [Outcome of surgical treatment for acromegaly performed by a single neurosurgeon and cumulative meta-analysis]. Boeving A, Borba LA, Rodrigues AM, Orichowski EB, Paz Filho GJ, Santos CM, Boguszewski CL. Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):884-92. PubMed ID: 17160212 [Abstract] [Full Text] [Related]
2. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly. Cardinal T, Rutkowski MJ, Micko A, Shiroishi M, Jason Liu CS, Wrobel B, Carmichael J, Zada G. Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366 [Abstract] [Full Text] [Related]
3. Acromegaly surgery in Manchester revisited--the impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission. Wang YY, Higham C, Kearney T, Davis JR, Trainer P, Gnanalingham KK. Clin Endocrinol (Oxf); 2012 Mar; 76(3):399-406. PubMed ID: 21824170 [Abstract] [Full Text] [Related]
5. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center. Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T. Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132 [Abstract] [Full Text] [Related]
6. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study. Edo N, Morita K, Suzuki H, Takeshita A, Miyakawa M, Fukuhara N, Nishioka H, Yamada S, Takeuchi Y. Endocr J; 2016 May 31; 63(5):469-77. PubMed ID: 26949262 [Abstract] [Full Text] [Related]
7. Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria. Anik I, Cabuk B, Gokbel A, Selek A, Cetinarslan B, Anik Y, Ceylan S. World Neurosurg; 2017 Dec 31; 108():278-290. PubMed ID: 28887283 [Abstract] [Full Text] [Related]
8. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas. Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ. Neurosurg Focus; 2010 Oct 31; 29(4):E5. PubMed ID: 20887130 [Abstract] [Full Text] [Related]
9. SIGNIFICANT ELEVATION OF GROWTH HORMONE LEVEL IMPACTS SURGICAL OUTCOMES IN ACROMEGALY. Anthony JR, Alwahab UA, Kanakiya NK, Pontell DM, Veledar E, Oyesiku NM, Ioachimescu AG. Endocr Pract; 2015 Sep 31; 21(9):1001-9. PubMed ID: 26121434 [Abstract] [Full Text] [Related]
10. Age- and Sex-Specific Differences as Predictors of Surgical Remission Among Patients With Acromegaly. Park SH, Ku CR, Moon JH, Kim EH, Kim SH, Lee EJ. J Clin Endocrinol Metab; 2018 Mar 01; 103(3):909-916. PubMed ID: 29272449 [Abstract] [Full Text] [Related]
11. Revisiting the Role of Insulin-like Growth Factor-1 Measurement After Surgical Treatment of Acromegaly. Jung IH, Choi S, Ku CR, Lee SG, Lee EJ, Kim SH, Kim EH. J Clin Endocrinol Metab; 2021 Jun 16; 106(7):e2589-e2599. PubMed ID: 33738470 [Abstract] [Full Text] [Related]
12. Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly. Cardinal T, Collet C, Wedemeyer M, Singer PA, Weiss M, Zada G, Carmichael JD. Front Endocrinol (Lausanne); 2021 Jun 16; 12():743052. PubMed ID: 34867787 [Abstract] [Full Text] [Related]
13. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. Biermasz NR, van Dulken H, Roelfsema F. J Clin Endocrinol Metab; 2000 Dec 16; 85(12):4596-602. PubMed ID: 11134114 [Abstract] [Full Text] [Related]
14. Acromegaly. Scacchi M, Cavagnini F. Pituitary; 2006 Dec 16; 9(4):297-303. PubMed ID: 17077948 [Abstract] [Full Text] [Related]
15. Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. Starke RM, Raper DM, Payne SC, Vance ML, Oldfield EH, Jane JA. J Clin Endocrinol Metab; 2013 Aug 16; 98(8):3190-8. PubMed ID: 23737543 [Abstract] [Full Text] [Related]
16. Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission. De P, Rees DA, Davies N, John R, Neal J, Mills RG, Vafidis J, Davies JS, Scanlon MF. J Clin Endocrinol Metab; 2003 Aug 16; 88(8):3567-72. PubMed ID: 12915637 [Abstract] [Full Text] [Related]
17. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. Freda PU, Wardlaw SL, Post KD. J Neurosurg; 1998 Sep 16; 89(3):353-8. PubMed ID: 9724106 [Abstract] [Full Text] [Related]
18. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria. Hazer DB, Işık S, Berker D, Güler S, Gürlek A, Yücel T, Berker M. J Neurosurg; 2013 Dec 16; 119(6):1467-77. PubMed ID: 24074496 [Abstract] [Full Text] [Related]
19. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years. Abbassioun K, Amirjamshidi M, Mehrazin A, Khalatbary I, Keynama M, Bokai H, Abdollahi M. Surg Neurol; 2006 Jul 16; 66(1):26-31; discussion 31. PubMed ID: 16793431 [Abstract] [Full Text] [Related]
20. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly. Bourdelot A, Coste J, Hazebroucq V, Gaillard S, Cazabat L, Bertagna X, Bertherat J. Eur J Endocrinol; 2004 Jun 16; 150(6):763-71. PubMed ID: 15191345 [Abstract] [Full Text] [Related] Page: [Next] [New Search]